← Open Payments lookup

WENDY ROGERS: Open Payments

NPI 1437749264 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,364 in 249 payments from 14 companies in 2025. Trend: 2023 $2,310 · 2024 $2,696 · 2025 $4,364

Food & beverage: $4,292Education: $71
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.39$824
Neurocrine BioSciences, Inc.32$699
Vanda Pharmaceuticals Inc.31$645
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)31$504
Teva Pharmaceuticals USA, Inc.36$464
E.R. Squibb & Sons, L.L.C.22$416
ABBVIE INC.32$372
Alkermes, Inc.12$170
Lundbeck LLC4$73
Axsome Therapeutics, Inc.3$66

Products named: REXULTI, INGREZZA, FANAPT, CAPLYTA, COBENFY, VRAYLAR, AUSTEDO XR, UZEDY.

Industry payments across TX — which companies pay providers there.